Gilead Sciences, Inc. (GILD)

EC Approves Label Expansion of GILD's Trodelvy in First-line Metastatic TNBC

3 Dividend Stocks to Hold for the Next 10 Years

European Commission Expands Role of Gilead's Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across PD-L1 Status

Advisors Capital Management LLC Takes Position in Gilead Sciences, Inc. $GILD

Allworth Financial LP Invests $5.96 Million in Gilead Sciences, Inc. $GILD

In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?

59,974 Shares in Gilead Sciences, Inc. $GILD Purchased by Abacus FCF Advisors LLC

Worried About a Market Crash? These 3 Stocks Beat the S&P 500 in 2008 and 2022

Aljian Capital Management LLC Invests $568,000 in Gilead Sciences, Inc. $GILD

Is Gilead's Expanding HIV Portfolio a Growth Catalyst?

Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.

Capital Financial Group Inc. Co. ADV Invests $582,000 in Gilead Sciences, Inc. $GILD

AMG National Trust Bank Purchases Shares of 26,675 Gilead Sciences, Inc. $GILD

Assembly Biosciences: Gilead Advancements For GS-1179 And ABI-6250 Is A Bullish Signal

BIP Wealth LLC Purchases New Holdings in Gilead Sciences, Inc. $GILD

Abundance Wealth Counselors Grows Stake in Gilead Sciences, Inc. $GILD

Benjamin Edwards Inc. Has $15.86 Million Stock Holdings in Gilead Sciences, Inc. $GILD

Court rules companies can't import Gilead medications from overseas in blow to AFP health programs

First Bank & Trust Lowers Stock Position in Gilead Sciences, Inc. $GILD